About 7 Trademarks found for “IP*DA”

Association services, namely, promoting best practices in infection prevention and control; association services namely, promoting awareness of the need for improving patient and staff care by serving the needs and aims common to all persons involved in infection prevention and control activities; promoting the interests of members involved in the field of infection protection and control;

Educational services, namely, providing healthcare professionals with online instruction and courses in the field of infection prevention and control; arranging and conducting lectures, seminars and continuing education programs in the field of infection protection and control; arranging and conducting conferences in the field of infection protection and control; arranging and conducting Internet seminars (webinars) in the field of infection protection and control; publication of articles, newsletters, bulletins and books relating to infection protection and control;

Bed covers; canvas for embroidery; cotton fabric; elastic yarn mixed fabrics; furnishing and upholstery fabrics; linen for household purposes; loose covers for furniture; mattress covers; tablecloths, not of paper

Ipe wood decking supply

Ipe wood decking

Ipe wood decking supply

Chemicals for use in the manufacture of cosmetic, and chemicals for use in the manufacture of pharmaceutical preparations namely pharmaceutical preparations for use in oncology, pharmaceutical preparations for the treatment of endocrine diseases namely disorders of the thyroid namely thyroid cancer, thyroid nodules, primary hyperparathyroidism, hyperthyroidism, hypothyroidism, thyroiditis, parathyroid, adrenal and pituitary glands, acromegaly, diabetes, hypercosticism, hyperlipoproteinemia, hyperprolactinemia, hypoglycemia, pheochromocytoma, polyuropolydipsic syndrome, pharmaceutical preparations for the treatment of neurological diseases namely neurodegenerative diseases, neurosensory disorders, pain traumatisms, spinal cord injuries, neuromuscular disorders, convulsions, motor and sensory sequelae of cerebral origin, motor and sensory sequelae of medullary injury, cerebellar syndrome, muscle tone disorders and tremors, neurocognitive and neuropsychiatric sequelae, peripheral nervous system damage namely damage to upper and lower limbs, sensory, painful and trophic phenomena, sciatica and cervicobrachialgia, cranial nerve damage, damage linked to certain neurological syndromes namely post-concussion syndrome, epilepsy, parkinsonian syndromes, post-traumatic spinal syndrome, pharmaceutical preparations for the treatment of hematological disorders namely adenopathy, anemia, intravascular coagulation, sickle-cell anemia, monoclonal dysglobulinemia, leukemia, malignant non-Hodgkin's lymphomas, purpura, splenomegaly, hemorrhagic syndrome, mononucleosis syndromes, Hodgkin's disease, multiple myeloma, thalassemia, thrombopenia, polycythemia vera, pharmaceutical preparations for the treatment of gastroenterological diseases and disorders, and for the treatment of cardiovascular and cognitive disorders, pharmaceutical preparations for the treatment of urological diseases, pharmaceutical preparations for the treatment and prevention of neuromuscular disorders namely medicines nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, movement disorders, focal dystonia, cervical dystonia, pharmaceutical preparations for the treatment of muscular disorders namely muscular atrophy, muscular dystrophy, muscular dystonia, muscle spasms, neck strain, cramps, pharmaceutical preparations for the treatment of orthopedic disorders namely hip dislocation, spinal column deformation, curvature of the spine namely scoliosis, lordosis, cyphosis, pharmaceutical preparations for the treatment of disorders relating to age namely senile dementia, emphysema, Alzheimer's, and age-related macular degeneration, pharmaceutical preparations for the relief of pain, muscle spasm, hemifacial spasm and blepharospasm, pharmaceutical preparations for the treatment and prevention of cervical dystonia, torticollis, cerebral palsy, and spasticity, pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, namely dermatitis, eczema, skin lesions, hyperkeratosis, skin irritations, rosacea, psoriasis, acne, wound scars, pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and botulinum toxin derivatives used for the treatment of spasms and dystonias, cervical dystonia, focal dystonia, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, movement disorders, torticollis and cerebral pasly, muscle disorders and muscle spasms, hemifacial spasm and blepharospasm, chronic migraine, severe primary axillary hyperhidrosis, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin namely glabellar lines, wrinkles, and to prevent the development of wrinkles, pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and botulinum toxin derivatives for use in cosmetic surgery

Pharmaceutical preparations for use in oncology, pharmaceutical preparations for the treatment of endocrine diseases namely disorders of the thyroid namely thyroid cancer, thyroid nodules, primary hyperparathyroidism, hyperthyroidism, hypothyroidism, thyroiditis, parathyroid, adrenal and pituitary glands, acromegaly, diabetes, hypercosticism, hyperlipoproteinemia, hyperprolactinemia, hypoglycemia, pheochromocytoma, polyuropolydipsic syndrome, pharmaceutical preparations for the treatment of neurological diseases namely neurodegenerative diseases, neurosensory disorders, pain traumatisms, spinal cord injuries, neuromuscular disorders, convulsions, motor and sensory sequelae of cerebral origin, motor and sensory sequelae of medullary injury, cerebellar syndrome, muscle tone disorders and tremors, neurocognitive and neuropsychiatric sequelae, peripheral nervous system damage namely damage to upper and lower limbs, sensory, painful and trophic phenomena, sciatica and cervicobrachialgia, cranial nerve damage, damage linked to certain neurological syndromes namely post-concussion syndrome, epilepsy, parkinsonian syndromes, post-traumatic spinal syndrome, pharmaceutical preparations for the treatment of hematological disorders namely adenopathy, anemia, intravascular coagulation, sickle-cell anemia, monoclonal dysglobulinemia, leukemia, malignant non-Hodgkin's lymphomas, purpura, splenomegaly, hemorrhagic syndrome, mononucleosis syndromes, Hodgkin's disease, multiple myeloma, thalassemia, thrombopenia, polycythemia vera, pharmaceutical preparations for the treatment of gastroenterological diseases and disorders, and for the treatment of cardiovascular and cognitive disorders; pharmaceutical preparations for the treatment of urological diseases; pharmaceutical preparations for the treatment and prevention of neuromuscular disorders namely medicines nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, movement disorders, focal dystonia, cervical dystonia; pharmaceutical preparations for the treatment of muscular disorders namely muscular atrophy, muscular dystrophy, muscular dystonia, muscle spasms, neck strain, cramps; pharmaceutical preparations for the treatment of orthopedic disorders namely hip dislocation, spinal column deformation, curvature of the spine namely scoliosis, lordosis, cyphosis; pharmaceutical preparations for the treatment of disorders relating to age namely senile dementia, emphysema, Alzheimer's, and age-related macular degeneration; pharmaceutical preparations for the relief of pain, muscle spasm, hemifacial spasm and blepharospasm; pharmaceutical preparations for the treatment and prevention of cervical dystonia, torticollis, cerebral palsy, and spasticity; pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, namely dermatitis, eczema, skin lesions, hyperkeratosis, skin irritations, rosacea, psoriasis, acne, wound scars; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and botulinum toxin derivatives used for the treatment of spasms and dystonias, cervical dystonia, focal dystonia, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, movement disorders, torticollis and cerebral pasly, muscle disorders and muscle spasms, hemifacial spasm and blepharospasm, chronic migraine, severe primary axillary hyperhidrosis, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin namely glabellar lines, wrinkles, and to prevent the development of wrinkles; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and botulinum toxin derivatives for use in cosmetic surgery